Anika Therapeutics Sees FY23 Revenue $164M-$166M Vs $161.29M Est.
Portfolio Pulse from Benzinga Newsdesk
Anika Therapeutics has projected its FY23 revenue to be between $164M-$166M, which is higher than the estimated $161.29M.
November 02, 2023 | 9:57 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Anika Therapeutics' FY23 revenue forecast is higher than the estimated $161.29M, indicating potential growth.
Anika Therapeutics' higher revenue forecast for FY23 compared to the estimate suggests potential growth for the company. This could positively impact the company's stock price in the short term as it indicates strong financial performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100